March 5 (Reuters) - QUANTUM GENOMICS SA ALQGC.PA :
* SECURES OPERATIONAL FLEXIBILITY AND GROWTH CAPITAL THROUGH
EQUITY LINE FINANCING WITH KEPLER CHEUVREUX
* ANNOUNCES IMPLEMENTATION OF EQUITY LINE FINANCING
FACILITY,
CAPPED AT EUR 24 MLN OVER A THREE-YEAR PERIOD, STRUCTURED AND
BACKED BY KEPLER CHEUVREUX
* EQUITY FINANCING PLAN WILL BEGIN WITH A EUR 6 MILLION
TRANCHE
STARTING 5 MARCH 2018
* RECRUITMENT FOR NEW-HOPE, A PHASE II CLINICAL STUDY IN
TREATING
HYPERTENSION, FASTER THAN PROJECTED
* TARGET PATIENT PROFILE IN QUID HF, A PHASE IIA CLINICAL
STUDY IN
TREATING HEART FAILURE, WIDENED
Source text for Eikon: ID:nACT52238
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))